What is Driving the Growth of the Artificial Saliva Market?

The global artificial saliva market was valued at USD 1.42 billion in 2024 and is projected to reach USD 3.58 billion by 2034, expanding at a CAGR of 9.70% during the forecast period (2025–2034). The rising prevalence of xerostomia (dry mouth syndrome), growing geriatric population, and increased cases of radiation-induced salivary gland dysfunction are the major drivers behind the market’s expansion.

As awareness of oral health increases globally, saliva substitutes are becoming essential in managing conditions caused by reduced salivary flow. These products mimic the natural properties of saliva, maintaining moisture and improving patient comfort. Moreover, technological advancements in formulations — such as enzyme-based artificial saliva and longer-lasting gels — are enhancing product effectiveness and consumer adoption.

Market Overview: What is the Artificial Saliva Market?

The artificial saliva market encompasses the production and distribution of saliva substitutes that help lubricate and moisten the mouth in patients suffering from xerostomia. This condition is commonly caused by aging, side effects of medications, chemotherapy, or autoimmune diseases like Sjögren’s syndrome.

Artificial saliva products aim to replicate the natural functions of saliva, such as aiding digestion, maintaining oral pH, and protecting teeth from decay. The growing patient population and technological progress in oral care products are major contributors to the increasing market demand.

Key Market Highlights:

• Rising prevalence of xerostomia and chronic oral diseases.

• Growing elderly population requiring saliva replacement therapies.

• Increased awareness of oral hygiene and comfort-enhancing products.

• Expanding product availability through online and retail pharmacies.

Market Size and Growth Analysis

• 2024 Market Value: USD 1.42 Billion

• 2034 Forecast Value: USD 3.58 Billion

• CAGR (2025–2034): 9.70%

The market growth is driven by the increasing number of patients undergoing radiotherapy, which often leads to dry mouth, and by the expanding range of product types, including sprays, gels, and dissolvable tablets. Additionally, innovations in biocompatible formulations are improving consumer satisfaction and long-term use.

Market Breakup by Form

1. Oral Spray:

   • The most popular and convenient form, offering quick relief and easy application.

   • Widely used among elderly and cancer patients undergoing radiotherapy.

2. Oral Rinse:

   • Provides broader coverage and is often recommended for patients with mild xerostomia.

   • Frequently used before bedtime to maintain moisture overnight.

3. Dissolving Tablets:

   • Portable, discreet, and effective for users with moderate dry mouth symptoms.

4. Gel:

   • Offers long-lasting moisture and protection, ideal for patients with severe xerostomia.

5. Powder and Others:

   • Powder forms are often mixed with water before use; others include enzyme-based formulations offering advanced protection.

Market Breakup by Age Group

1. Adult Segment:

   • Holds the largest market share due to the high prevalence of dry mouth in adults caused by medication side effects, stress, and chronic diseases.

2. Paediatric Segment:

   • Includes products formulated for children suffering from congenital conditions or medication-induced dryness.

3. Others:

   • Covers special groups such as elderly patients in long-term care facilities who rely on saliva substitutes regularly.

Market Breakup by Distribution Channel

1. Supermarkets and Hypermarkets:

   • Provide wide accessibility for over-the-counter artificial saliva products.

2. Hospital Pharmacies:

   • Key distribution channel for prescription-based or specialized formulations used in post-radiation care.

3. Retail Pharmacies:

   • Major outlet for commonly used sprays, gels, and rinses.

4. Others:

   • Includes online pharmacies, which are witnessing rapid growth due to convenience and product availability.

Market Breakup by Region

North America

• Dominates the global market, driven by high awareness of oral health, robust healthcare infrastructure, and the presence of major players such as GlaxoSmithKline and Bausch Health.

• Increasing adoption of artificial saliva among elderly and post-cancer patients.

Europe

• Growing geriatric population and rising prevalence of Sjögren’s syndrome contribute to market growth.

• Strong presence of research-based oral care companies and supportive healthcare policies.

Asia Pacific

• Expected to witness the fastest CAGR due to rising healthcare expenditure, large patient base, and growing awareness about oral care solutions in countries like India, China, and Japan.

Latin America

• Growth driven by expanding healthcare access and increasing cases of dry mouth associated with diabetes and medication use.

Middle East and Africa

• Market growth supported by improving healthcare infrastructure and growing product penetration through pharmacies and hospitals.

Key Market Drivers

• Increasing prevalence of xerostomia due to aging, medication use, and chronic illnesses.

• Technological advancements in saliva formulations, including enzyme-rich and long-lasting moisturizing gels.

• Rising adoption of over-the-counter oral care products.

• Growing geriatric population worldwide, especially in developed economies.

• Expanding e-commerce channels enhancing product reach and accessibility.

Market Trends

• Introduction of enzyme-based and biocompatible artificial saliva formulations.

• Development of portable and travel-friendly formats like dissolvable tablets and sprays.

• Integration of natural ingredients and pH-balancing compounds for improved oral comfort.

• Growing focus on personalized oral care for chronic dry mouth patients.

Market Challenges

Despite positive growth prospects, certain factors limit market expansion:

• Limited awareness in developing nations about dry mouth management.

• Short duration of relief provided by some products.

• High cost of enzyme-rich and specialty formulations.

• Regulatory challenges in obtaining approvals for new saliva substitute compositions.

Leading Companies in the Artificial Saliva Market

• Livealth Biopharma Pvt Ltd

• GlaxoSmithKline Plc

• Fresenius Kabi AG

• Honeywell International, Inc.

• Parnell Pharmaceuticals, Inc.

• Forward Science

• Biocosmetics Laboratories

• Bausch Health

These companies focus on product innovation, expanding distribution networks, and enhancing formulations with bioactive ingredients for longer-lasting relief. Many are also collaborating with dental specialists and hospitals to increase patient access and awareness.

Future Outlook: The Road Ahead

The artificial saliva market is poised for strong growth over the next decade as global awareness of oral health rises and as more people seek effective solutions for xerostomia. The integration of AI-driven formulation design and biological simulation technologies is expected to further improve product performance and patient outcomes.

Additionally, the development of eco-friendly packaging, organic formulations, and customized delivery systems will shape the market’s future. By 2034, the market is expected to evolve toward more sustainable, personalized, and clinically validated saliva substitutes catering to diverse patient needs.

Find More Reports

Dental Equipment Market

India Vitamin Gummies Market

India Medical Gases Market

Osteoarthritis Therapeutics Market

About Us:

Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.

Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.

Media Contact:

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com